Get all your news in one place.
100's of premium titles.
One app.
Start reading
MarketBeat
MarketBeat
Jordan Chussler

Hims & Hers in Free Fall: Why Analysts See Nearly 150% Upside

With the health care sector remaining mostly flat several weeks into 2026, one of last year’s success stories has turned into an investor nightmare as shares of Hims & Hers Health (NYSE: HIMS) continue to plummet from their record highs.

Since its all-time high of $64.65 on May 16, 2025, HIMS has lost a staggering 75.50%. That sell-off began in earnest in late September, but much of the damage to the telehealth provider has come this year.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.